Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linaclotide effects on gut microbiota in adults with constipation-predominant irritable bowel syndrome
ChiCTR1900027934Phase 4Completed
- Sponsor
- Department of Gastroenterology, Second Affiliated Hospital of the Army Medical University
- Start
- Jan 2020
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of linaclotide in irritable bowel syndrome (IBS), sponsored by Department of Gastroenterology, Second Affiliated Hospital of the Army Medical University. Primary endpoint: Changes in gut flora composition. Started Jan 2020; status: completed.
02
Drugs
linaclotide
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on ChiCTR1900027934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027934.